Pell Bio Med Technology Co Ltd
TWSE:6949
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pell Bio Med Technology Co Ltd
TWSE:6949
|
TW |
|
B
|
Banco de Sabadell SA
XBER:BDSB
|
ES |
|
Healthway Medical Corporation Ltd
SGX:5NG
|
SG |
|
Biosig Technologies Inc
NASDAQ:BSGM
|
US |
|
Seadrill Ltd
OSE:SDRL
|
BM |
Income Statement
Earnings Waterfall
Pell Bio Med Technology Co Ltd
Income Statement
Pell Bio Med Technology Co Ltd
| Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|
| Revenue | |||||
| Interest Expense |
2
|
3
|
4
|
5
|
|
| Revenue |
20
N/A
|
27
+35%
|
27
+3%
|
30
+9%
|
|
| Gross Profit | |||||
| Cost of Revenue |
(32)
|
(32)
|
(33)
|
(39)
|
|
| Gross Profit |
(12)
N/A
|
(5)
+59%
|
(5)
-7%
|
(9)
-70%
|
|
| Operating Income | |||||
| Operating Expenses |
(401)
|
(405)
|
(376)
|
(392)
|
|
| Selling, General & Administrative |
(135)
|
(137)
|
(137)
|
(142)
|
|
| Research & Development |
(266)
|
(267)
|
(238)
|
0
|
|
| Depreciation & Amortization |
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
(250)
|
|
| Operating Income |
(413)
N/A
|
(410)
+1%
|
(381)
+7%
|
(400)
-5%
|
|
| Pre-Tax Income | |||||
| Interest Income Expense |
13
|
17
|
13
|
0
|
|
| Gain/Loss on Disposition of Assets |
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
6
|
6
|
1
|
11
|
|
| Pre-Tax Income |
(395)
N/A
|
(387)
+2%
|
(367)
+5%
|
(389)
-6%
|
|
| Net Income | |||||
| Tax Provision |
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(395)
|
(387)
|
(367)
|
(389)
|
|
| Income to Minority Interest |
6
|
6
|
11
|
15
|
|
| Net Income (Common) |
(389)
N/A
|
(381)
+2%
|
(357)
+6%
|
(374)
-5%
|
|
| EPS (Diluted) |
-6.83
N/A
|
-6.57
+4%
|
-6.15
+6%
|
-6.33
-3%
|
|